白髪老人HM
liked
$Cipher Mining (CIFR.US)$ In the midst of SoftBank's financial problems, is this News of individual stocks? 😂
Translated
2
白髪老人HM
liked
$Gorilla Technology (GRRR.US)$
There may be many people who can't sleep tonight because they are unsure whether to take profits or hold before the market opens tomorrow.
I think both options are correct this time.
① Exit temporarily
Hold
However, even looking at overseas bulletin boards and other communities, there are overwhelmingly more opinions about re-entering at lower levels, even if you chose option 1. People who chose option 2 not only care about the numbers, but also want to know the progress of various large contracts.
In other words, the reason why there are overwhelmingly more investors expecting this stock even in this market crash is because they are hoping for strong fundamentals.
[Revenue Trend]
In 2023, actual sales reached 65 million dollars.
In 2024, it is expected to reach 72 million dollars.
In 2025, it is expected to reach 100 million dollars.
The numbers in 2 and 3 are values that are not included in the following contracts yet, and once these are determined, there will be a significant increase in sales revenue, so there is no reason for the stock price not to rise. Additionally, as it is a high-profit margin business, there are high expectations for net profit.
- Mainland Education project in Southeast Asia worth 438 million dollars
- Satellite communications project with Broad Sat, initial year estimated at 70 million dollars
- And many others
Even now, the stocks are undervalued, but if these can be contracted smoothly, there is no reason for the stock price not to rise...
There may be many people who can't sleep tonight because they are unsure whether to take profits or hold before the market opens tomorrow.
I think both options are correct this time.
① Exit temporarily
Hold
However, even looking at overseas bulletin boards and other communities, there are overwhelmingly more opinions about re-entering at lower levels, even if you chose option 1. People who chose option 2 not only care about the numbers, but also want to know the progress of various large contracts.
In other words, the reason why there are overwhelmingly more investors expecting this stock even in this market crash is because they are hoping for strong fundamentals.
[Revenue Trend]
In 2023, actual sales reached 65 million dollars.
In 2024, it is expected to reach 72 million dollars.
In 2025, it is expected to reach 100 million dollars.
The numbers in 2 and 3 are values that are not included in the following contracts yet, and once these are determined, there will be a significant increase in sales revenue, so there is no reason for the stock price not to rise. Additionally, as it is a high-profit margin business, there are high expectations for net profit.
- Mainland Education project in Southeast Asia worth 438 million dollars
- Satellite communications project with Broad Sat, initial year estimated at 70 million dollars
- And many others
Even now, the stocks are undervalued, but if these can be contracted smoothly, there is no reason for the stock price not to rise...
Translated
38
4
白髪老人HM
liked
Translated
4
白髪老人HM
liked
$Opus Genetics (IRD.US)$
Due to the agreement on SPA, the outlook for the clinical trial of APX3330 has improved.
In general, SPA refers to a pre-agreement between the FDA and pharmaceutical organizations on "the method of clinical trials" and "criteria for determining results to be valid". Therefore, there is a risk that the result could be "We made an SPA but failed to confirm the agreed effectiveness".
The final outcome will depend on how many participants are recruited for the Phase III trial, and it usually takes at least 10 months from the start of the Phase III trial. Therefore, it is highly likely to attract day traders and Short Sell tactics multiple times.
At least the next financial statement is expected to show a significant decline in red.
Due to the agreement on SPA, the outlook for the clinical trial of APX3330 has improved.
In general, SPA refers to a pre-agreement between the FDA and pharmaceutical organizations on "the method of clinical trials" and "criteria for determining results to be valid". Therefore, there is a risk that the result could be "We made an SPA but failed to confirm the agreed effectiveness".
The final outcome will depend on how many participants are recruited for the Phase III trial, and it usually takes at least 10 months from the start of the Phase III trial. Therefore, it is highly likely to attract day traders and Short Sell tactics multiple times.
At least the next financial statement is expected to show a significant decline in red.
Translated
5
白髪老人HM
liked
$Dow Jones Industrial Average (.DJI.US)$
I was investing in Funds with the growth investment frame of NISA in Dow Jones Industrial Average, but I canceled and cashed it out 9 days ago. Next year, I plan to invest in individual stocks of 🇺🇸 US stocks and 🇨🇳 China Connect stocks, timing it right.
I was investing in Funds with the growth investment frame of NISA in Dow Jones Industrial Average, but I canceled and cashed it out 9 days ago. Next year, I plan to invest in individual stocks of 🇺🇸 US stocks and 🇨🇳 China Connect stocks, timing it right.
Translated
2
白髪老人HM
liked
$Gorilla Technology (GRRR.US)$ One of the ideal stocks that becomes more valuable as its popularity increases due to the consolidation of 10 shares.
Translated
7
白髪老人HM
liked
Translated
7
白髪老人HM
liked
$Rigetti Computing (RGTI.US)$ Too early
Translated
10
$Payoneer Global (PAYO.US)$ Great financial results. A major eruption of 20%. Even $20 is in sight.
Translated
$Marqeta (MQ.US)$ A 42% drop. A massive crash. The performance is poor, is there hope for the future?.
Translated
2
![[empty]](https://static.moomoo.com/node_futunn_nnq/assets/images/folder.5c37692712.png)
![[error]](https://static.moomoo.com/node_futunn_nnq/assets/images/no-network.991ae8055c.png)
![[loading]](data:image/svg+xml;base64,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)